Çalışkan Fatih, Akdemir Hızır Ufuk, Nurata Hakan, Akdemir Neslihan, Başara Gökhan, Yavuz Yücel
Department of Emergency Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Department of Emergency Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Am J Emerg Med. 2015 Mar;33(3):475.e1-5. doi: 10.1016/j.ajem.2014.08.028. Epub 2014 Aug 21.
Bleeding, the most frightening adverse effect of anticoagulants,may occur in different parts of the body.When intracerebral hemorrhage in individuals used anticoagulant drugs is compared with normal coagulation function, the volume of bleeding is increased and the prognosis is worse. There are few studies in the literature regarding the presence of intracerebral hemorrhage and the volume and prognosis of bleeding associated with rivaroxaban, a new oral anticoagulant.Therefore, the clinical and radiologic findings and follow-up of an 80-year-old male patient with intracerebral hemorrhage who uses rivaroxaban for anticoagulation are presented in this article.
出血是抗凝剂最可怕的不良反应，可能发生在身体的不同部位。与凝血功能正常的个体相比，使用抗凝药物的个体发生脑出血时，出血量会增加且预后更差。关于新型口服抗凝剂利伐沙班相关的脑出血情况、出血量及预后，文献中的研究较少。因此，本文介绍了一名使用利伐沙班进行抗凝治疗的80岁男性脑出血患者的临床和影像学表现及随访情况。
